$APOG

Apogee Non-GAAP EPS of $1.17 beats by $0.53, revenue of $391.1M beats by $39.69M (APOG:NASDAQ)

Apogee Enterprises (APOG) reported Q2 Non-GAAP EPS of $1.17, beating estimates by $0.53, with revenue of $391.1M, up 9.2% year-over-year and exceeding expectations by $39.69M. The company raised its fiscal 2027 adjusted diluted EPS guidance to $3.00-$3.40, up from $2.70-$3.25, with a consensus at $2.87. Shares rose 2.5% premarket.

Original reporting
Published Oct 6, 2026, 10:35 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 10:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$APOG
Bullish
high confidence
Mentioned
$APOG
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$APOGBullishMed
01

Why it matters

The earnings beat and guidance raise provide fresh material for traders to consider positioning ahead of market open.

02

Market read

Earnings surprise and guidance upgrade are primary catalysts for short-term price movement.

03

What to watch

Potential margin pressure from rising costs could offset earnings momentum.

Relevance 7/10Novelty 8/10Timing: pre-market today

Background

Apogee Enterprises is a small-cap industrial services firm that recently announced an acquisition of GroGlass.

Company-level read

Ticker impact

$APOGBullishHigh confidence
Context

Apogee Enterprises reported Q2 Non-GAAP EPS of $1.17 beating estimates and raised FY2027 EPS guidance to $3.00-$3.40.

Expected impact

upward pressure as market prices in the earnings beat and higher guidance

Evidence & confidence

Both EPS beat and guidance raise are fresh primary disclosures that typically drive short-term buying.

Market effects

Positive for the broader industrial services sector as earnings beat may signal demand strength.

Limited to U.S. markets where APOG trades.

Low, confined to the company and its sector.

Counterpoint

If the beat is already priced in, the stock may face short-term profit taking.

Key entities

  • Apogee Enterprises, Inc.

    Issuer of the earnings report.

Related articles

$LWHighAI 8/10

US Stock Movers: Lamb Weston, Option Care, Apogee Rally

Lamb Weston (LW) shares rose 11.85% after reporting Q1 sales of $1.67B and raising 2027 EBITDA guidance. Option Care (OPCH) jumped 32.8% on a $5.8B take-private deal. Apogee (APOG) gained 18.7% on strong Q2 earnings and raised FY2027 outlook. Constellation (CEG) surged 14.79% after a Google nuclear deal. RPM (RPM) rose 2.5% on record Q1 results.

$APOGHighAI 8/10

Apogee (APOG) Q2 2027 Earnings Call Transcript

Apogee (APOG) reported Q2 2027 earnings with net sales up 9.2% to $391.1M, driven by acquisitions and pricing. Adjusted EBITDA margin rose to 12.7%, and EPS increased 19% to $1.17. The company highlighted progress in metals, services, and glass segments, with services delivering 10 consecutive quarters of growth. Acquisitions of Kalwall and GrowGlass are expected to enhance capabilities and profitability. Management expressed confidence in long-term growth and shareholder value creation.

$APOGMedAI 8/10

Apogee Enterprises Inc (APOG) (Q2 2027) Earnings Call Highlights: Raised Guidance

Apogee Enterprises (APOG) reported Q2 2027 revenue of $391M, up 9% YoY, and adjusted EPS of $1.17, up 19%. The company raised its fiscal 2027 outlook due to strong first-half performance. Segment performance varied, with Services growing for the 10th consecutive quarter, while Glass and Performance Surfaces faced challenges. Acquisitions of Kalwall and Groglass are progressing well. Leverage ratio is 1.7 times, slightly above target. The company repurchased $6.4M of stock in Q2.

$APOGHighAI 8/10

Apogee raises fiscal 2027 guidance after second-quarter sales rise

Apogee Enterprises (APOG) reported a 9.2% sales increase to $391.1M in Q2, raising its fiscal 2027 adjusted EPS guidance to $3.00-$3.40 and net sales outlook to $1.46B-$1.50B. Operating income rose 24.5% to $33.5M, while net earnings fell 5.4% to $22.4M. Growth was driven by acquisitions, pricing, and product mix, though offset by lower volume and higher costs.